Cboe Stock Analysis Cboe Global Markets Inc Posts 3.45 Percent Daily Gain Amid Exchange Sector Strength 20260403 1 Regeneron Pharmaceuticals REGN Dupixent Secures FDA Approval as First Biologic for Pediatric Chronic Spontaneous Urticaria Expanding Blockbuster Drugs Addressable Market BWMN Bowman reports 149 year over year revenue growth but misses EPS estimates by 59 stock edges lower DHC Div Health posts sharp Q3 2024 EPS beat but shares fall 266 percent on tepid revenue growth worries Public Storage PSA Announces First Quarter 2026 Earnings Release Schedule and Investor Conference Call